Literature DB >> 4440452

Appraisal of long-term levodopa treatment of parkinsonism with special reference to therapy limiting factors.

J Presthus, R Holmsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4440452     DOI： 10.1111/j.1600-0404.1974.tb02818.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN： 0001-6314            Impact factor:   3.209


× No keyword cloud information.
  5 in total

Review 1.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

2.  Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial.

Authors:  U K Rinne; E Birket-Smith; E Dupont; E Hansen; M Hyyppä; R Marttila; B Mikkelsen; H Pakkenberg; J Presthus
Journal:  J Neurol       Date:  1975-12-02       Impact factor: 4.849

Review 3.  Drug-induced mania.

Authors:  M Peet; S Peters
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

Review 4.  Drug-induced mania in the elderly.

Authors:  L Ganzini; S B Millar; J R Walsh
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

Review 5.  Drug-induced mania--causative agents, clinical characteristics and management. A retrospective analysis of the literature.

Authors:  D L Sultzer; J L Cummings
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.